Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Olema Pharmaceuticals Inc., 3 years.
Olema Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 17, 2024 | Olema Pharmaceuticals Inc. | Open-market sale | −700,761 | $6.75 | $4,730,137 |
| Dec 17, 2024 | Olema Pharmaceuticals Inc. | Open-market purchase | −700,761 | $6.75 | $4,730,137 |
| Jun 4, 2024 | Olema Pharmaceuticals Inc. | Open-market sale | −700,000 | $14.85 | $10,395,000 |
| Jun 4, 2024 | Olema Pharmaceuticals Inc. | Open-market sale | −475,000 | $14.85 | $7,053,750 |
| Dec 5, 2023 | Olema Pharmaceuticals Inc. | Open-market purchase | +31,870 | $14.73 | $469,445 |
| Dec 5, 2023 | Olema Pharmaceuticals Inc. | Open-market purchase | +50,000 | $14.95 | $747,500 |
| Dec 5, 2023 | Olema Pharmaceuticals Inc. | Open-market purchase | +50,000 | $13.09 | $654,500 |
| Sep 12, 2023 | Olema Pharmaceuticals Inc. | Open-market purchase | +508,130 | $9.84 | $4,999,999 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.